Teva Pharmaceutical Industries (TEVA) Financials

TEVA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 43.5 billion 35.4 billion
2023-09-30 42.1 billion 34.6 billion
2023-06-30 43.1 billion 35.4 billion
2023-03-31 43.5 billion 34.8 billion

TEVA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 1.1 billion 28.0 million
2023-09-30 -144.0 million 31.0 million
2023-06-30 205.0 million 30.0 million
2023-03-31 -284.0 million 32.0 million

TEVA Net Income

No data available :(

TEVA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 3.2 billion - 320.0 million
2023-09-30 2.2 billion - 324.0 million
2023-06-30 2.7 billion - 338.0 million
2023-03-31 2.1 billion - 345.0 million

TEVA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 1.1 billion
2023-09-30 1.1 billion
2023-06-30 1.1 billion
2023-03-31 1.1 billion

TEVA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 119.0 million 227.0 million 292.0 million 610.0 million
2023-09-30 149.0 million 253.0 million 268.0 million 576.0 million
2023-06-30 119.0 million 240.0 million 307.0 million 603.0 million
2023-03-31 139.0 million 234.0 million 296.0 million 546.0 million

TEVA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 4.5 billion 2.0 billion
2023-09-30 3.9 billion 2.0 billion
2023-06-30 3.9 billion 2.1 billion
2023-03-31 3.7 billion 2.1 billion

TEVA

Price: $14.06

52 week price:
7.09
14.47

Payout Ratio Range:
-45.00%
9189.19%

Earnings Per Share: -0.50 USD

P/E Ratio: -24.76

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 6.4 million

Ebitda: -12.5 billion

Market Capitalization: 15.9 billion

Average Dividend Frequency: 4

Links: